2024 ICD-10-CM Diagnosis Code Q13.1
Absence of iris
- ICD-10-CM Code:
- Q13.1
- ICD-10 Code for:
- Absence of iris
- Is Billable?
- Yes - Valid for Submission
- Chronic Condition Indicator: [1]
- Chronic
- Code Navigator:
- Code Information
- Approximate Synonyms
- Clinical Classification
- Clinical Information
- Tabular List of Diseases and Injuries
- Index to Diseases and Injuries References
- Diagnostic Related Groups Mapping
- Present on Admission (POA)
- Convert to ICD-9 Code
- Patient Education
- Other Codes Used Similar Conditions
- Code History
Q13.1 is a billable diagnosis code used to specify a medical diagnosis of absence of iris. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- 11p partial monosomy syndrome
- Aniridia and absent patella syndrome
- Aniridia and intellectual disability syndrome
- Aniridia type 1
- Aniridia type 2
- Aniridia, ptosis, intellectual disability, familial obesity syndrome
- Aniridia, renal agenesis, psychomotor retardation syndrome
- Bilateral congenital aniridia of eyes
- Congenital aniridia
- Congenital aniridia
- Congenital aniridia
- Congenital aniridia
- Congenital aniridia
- Congenital aniridia of left eye
- Congenital aniridia of right eye
- Congenital anomaly of patella
- Deletion of part of chromosome 11
- Renal agenesis
- WAGR syndrome
Clinical Classification
Clinical Category is Congenital malformations of eye, ear, face, neck
- CCSR Category Code: MAL005
- Inpatient Default CCSR: Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.
- Outpatient Default CCSR: Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.
Clinical Information
WAGR Syndrome
a contiguous gene syndrome associated with hemizygous deletions of chromosome region 11p13. the condition is marked by the combination of wilms tumor; aniridia; genitourinary abnormalities; and intellectual disability.Bilateral Renal Agenesis
a congenital abnormality characterized by the absence of both kidneys.Renal Agenesis
a congenital abnormality characterized by the absence of one or both kidneys.Unilateral Renal Agenesis|Congenital Single Kidney|Congenital Solitary Kidney|Congenital Solitary Kidney
a congenital abnormality characterized by the presence of only one kidney.
Tabular List of Diseases and Injuries
The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.
Inclusion Terms
Inclusion TermsThese terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Aniridia
Use Additional Code
Use Additional CodeThe “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.
- code for associated glaucoma H42
Index to Diseases and Injuries References
The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).
- - Agenesis
- - iris (dilator fibers) - Q13.1
- - Aniridia (congenital) - Q13.1
- - Glaucoma - H40.9
- - in (due to)
- - aniridia - Q13.1
- - in (due to)
- - Irideremia - Q13.1
Present on Admission (POA)
Q13.1 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
CMS POA Indicator Options and Definitions
POA Indicator | Reason for Code | CMS will pay the CC/MCC DRG? |
---|---|---|
Y | Diagnosis was present at time of inpatient admission. | YES |
N | Diagnosis was not present at time of inpatient admission. | NO |
U | Documentation insufficient to determine if the condition was present at the time of inpatient admission. | NO |
W | Clinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission. | YES |
1 | Unreported/Not used - Exempt from POA reporting. | NO |
Convert Q13.1 to ICD-9-CM
- ICD-9-CM Code: 743.45 - Aniridia
Patient Education
Eye Diseases
Some eye problems are minor and don't last long. But some can lead to a permanent loss of vision.
Common eye problems include:
- Refractive errors
- Cataracts - clouded lenses
- Optic nerve disorders, including glaucoma
- Retinal disorders - problems with the nerve layer at the back of the eye
- Macular degeneration - a disease that destroys sharp, central vision
- Diabetic eye problems
- Conjunctivitis - an infection also known as pink eye
Your best defense is to have regular checkups, because eye diseases do not always have symptoms. Early detection and treatment could prevent vision loss. See an eye care professional right away if you have a sudden change in vision, if everything looks dim, or if you see flashes of light. Other symptoms that need quick attention are pain, double vision, fluid coming from the eye, and inflammation.
NIH: National Eye Institute
[Learn More in MedlinePlus]
Aniridia
Aniridia is an eye disorder characterized by a complete or partial absence of the colored part of the eye (the iris). These iris abnormalities may cause the pupils to be abnormal or misshapen. Aniridia can cause reduction in the sharpness of vision (visual acuity) and increased sensitivity to light (photophobia).
People with aniridia can also have other eye problems. Increased pressure in the eye (glaucoma) typically appears in late childhood or early adolescence. Clouding of the lens of the eye (cataracts), occur in 50 percent to 85 percent of people with aniridia. In about 10 percent of affected people, the structures that carry information from the eyes to the brain (optic nerves) are underdeveloped. Individuals with aniridia may also have involuntary eye movements (nystagmus) or underdevelopment of the region at the back of the eye responsible for sharp central vision (foveal hypoplasia). Many of these eye problems contribute to progressive vision loss in affected individuals. The severity of symptoms is typically the same in both eyes.
Rarely, people with aniridia have behavioral problems, developmental delay, and problems detecting odors.
[Learn More in MedlinePlus]
Code History
- FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.